Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson's Patients

Neuromodulation : Journal of the International Neuromodulation Society
Marleen EijkholtJulie G Pilitsis

Abstract

Deep brain stimulation (DBS) is a well-established treatment for the management of severe motor fluctuations in advanced Parkinson's disease (PD). Until recently, device regulation, medical, and insurance practices limited DBS to patients with advanced stages of PD. In February 2016 this changed, however, when the US Food and Drug Administration (FDA) granted formal approval for the use of brain stimulator in mid-stage PD patients. In this article, we examine whether DBS in mid-stage PD can be ethically justified beyond the FDA approval. We scrutinize the current risk-benefit profile, the costs-benefit profile, and the capacity for informed consent requirement, to ask if use of subthalamic nucleus (STN) in mid-stage DBS is ethically appropriate. We propose that mid-stage DBS decisions could be appropriate under a shared decision-making model, which embraces a broad quality of life perspective. Although it might be too premature to know how the FDA decision will affect medical and insurance practices, we conclude by arguing that revisions to persisting guidelines seems justified both on scientific and ethical grounds.

References

Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Jan 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·J MarinusA M Stiggelbout
Apr 12, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Anthony E Lang, Hakan Widner
Aug 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·A Diamond, J Jankovic
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katia NoyesAndrew W Dick
Oct 5, 2006·Journal of Neural Transmission. Supplementum·Y AgidM L Welter
Jan 24, 2008·Nature Clinical Practice. Neurology·W M Michael Schüpbach, Yves Agid
Jan 8, 2009·JAMA : the Journal of the American Medical Association·Frances M WeaverUNKNOWN CSP 468 Study Group
Jan 17, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C VossiusJ P Larsen
Sep 15, 2009·AJNR. American Journal of Neuroradiology·D DormontE Bardinet
Mar 30, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y WinterR Dodel
Jul 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Alberto J EspayMark H Eckman
Aug 26, 2010·JAMA : the Journal of the American Medical Association·Alexander A Kon
Oct 13, 2010·Archives of Neurology·Jeff M BronsteinMahlon R DeLong
Oct 15, 2010·The New England Journal of Medicine·Peter J Neumann, Milton C Weinstein
Jul 8, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinAnette Schrag
Jul 23, 2011·Frontiers in Integrative Neuroscience·Emma Sarah McIntosh
Sep 6, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Elyne KahnPeter Konrad
Nov 23, 2011·Parkinsonism & Related Disorders·P D CharlesP E Konrad
Dec 23, 2011·Stereotactic and Functional Neurosurgery·Julie G PilitsisJennifer F Tseng
Mar 2, 2012·The New England Journal of Medicine·Michael J Barry, Susan Edgman-Levitan
Feb 15, 2013·The New England Journal of Medicine·W M M SchuepbachUNKNOWN EARLYSTIM Study Group
Mar 14, 2013·Annals of Neurology·Ruth-Mary deSouzaAnthony H V Schapira
Apr 12, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Judith DamsJens-Peter Reese
May 1, 2013·Progress in Neurobiology·Christiane WoopenLars Timmermann
Jun 8, 2013·Parkinsonism & Related Disorders·Martijn van der EijkBastiaan R Bloem
Sep 21, 2013·Lancet Neurology·Marwan Hariz
Nov 19, 2013·Journal of Neurosurgery·Albert J Fenoy, Richard K Simpson
Apr 29, 2014·Parkinsonism & Related Disorders·David CharlesThomas L Davis
Sep 18, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Tiago A MestreAnthony E Lang
Feb 5, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Salvatore Galati, Alessandro Stefani
Nov 10, 2015·Current Opinion in Neurology·Daniela Ovadia, Gabriella Bottini
Dec 8, 2015·Parkinsonism & Related Disorders·Mallory HackerStuart Finder
Mar 12, 2016·Journal of Parkinson's Disease·Mallory L HackerDavid Charles

❮ Previous
Next ❯

Citations

Mar 14, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anna MallachKambiz N Alavian
Sep 28, 2017·Parkinson's Disease·Gerson Suarez-CedenoMya C Schiess

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.